FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vittorio Pengo

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
A Bontadi; Emanuela Falcinelli; S Giannini; A Hoxha; A Marturano; Stefania Momi; Vittorio Pengo; L Punzi; Amelia Ruffatti; Marta Tonello; Paolo Gresele
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Amelia Ruffatti; Giorgio Svaluto-Moreolo; Maria Tibaldi; A Calligaro; Maria Favaro; Chiara Grava; Ariela Hoxha; Luca Marozio; Piero Marson; Vittorio Pengo; Leonardo Punzi
A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro/La-related congenital atrioventricular block. A case series and review of the literature.
Gualtiero Palareti; Vittorio Pengo; Andrea Rubboli; Walter Ageno; Annamaria Ferrari; Alessandro Filippi; Davide Imberti; Danilo Toni
Clinical management of rivaroxaban-treated patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vittorio Pengo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Bontadi; Emanuela Falcinelli; S Giannini; A Hoxha; A Marturano; Stefania Momi; Vittorio Pengo; L Punzi; Amelia Ruffatti; Marta Tonello; Paolo Gresele
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Thrombosis and haemostasis 2013;109(5):901-8.
2013: Amelia Ruffatti; Giorgio Svaluto-Moreolo; Maria Tibaldi; A Calligaro; Maria Favaro; Chiara Grava; Ariela Hoxha; Luca Marozio; Piero Marson; Vittorio Pengo; Leonardo Punzi
A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro/La-related congenital atrioventricular block. A case series and review of the literature.
Autoimmunity reviews 2013;12(7):768-73.
2013: Gualtiero Palareti; Vittorio Pengo; Andrea Rubboli; Walter Ageno; Annamaria Ferrari; Alessandro Filippi; Davide Imberti; Danilo Toni
Clinical management of rivaroxaban-treated patients.
Expert opinion on pharmacotherapy 2013;14(5):655-67.
2013: Benilde Cosmi; Angelo Ghirarduzzi; Cristina Legnani; Gualtiero Palareti; Vittorio Pengo; Daniela Poli; Domenico Prisco; Sophie Testa; Armando Tripodi
The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
Thrombosis and haemostasis 2013;109(3):510-6.
2013: G Denas; Nicoletta Erba; T Fierro; Paolo Gresele; Sabino Iliceto; S Padayattil Jose; A Bracco; V De Micheli; D Poli; R Quintavalla; S Testa; Vittorio Pengo
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study.
Journal of thrombosis and thrombolysis 2013;35(2):178-84.
2012: Vittorio Pengo
ISTH guidelines on lupus anticoagulant testing.
Thrombosis research 2012;130 Suppl 1():S76-7.
2012: Vittorio Pengo; D Poli; S Siragusa; S Testa; E Tiraferri; A Tosetto; A Tripodi; L Crippa; A Falanga; G Finazzi; F Marongiu; Marco Moia; Gualtiero Palareti; C Manotti
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results.
Journal of thrombosis and haemostasis : JTH 2012;10(10):1979-87.
2012: M Milan; Franco Noventa; Vittorio Pengo; E Campello; L Filippi; Angelo Ghirarduzzi; V Vedovetto; Paolo Prandoni
Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study.
Journal of thrombosis and haemostasis : JTH 2012;10(10):2205-6.
2012: Francesco Marongiu; Vittorio Pengo; Daniela Poli; Sophie Testa; Guido Finazzi; Armando Tripodi
Management of special conditions in patients on vitamin K antagonists.
Internal and emergency medicine 2012;7(5):407-13.
2012: A Hoxha; Vittorio Pengo; A Banzato; A Bontadi; Amelia Ruffatti; E Salvan; Marta Tonello; L Punzi
Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
Lupus 2012;21(7):787-9.
2012: A Banzato; E Bison; A Bracco; S Cuffaro; Vincenzo De Filippis; G Denas; Roberta Frasson; A Hoxha; Sabino Iliceto; L Acquasaliente; Amelia Ruffatti; Vittorio Pengo
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome.
Lupus 2012;21(7):784-6.
2012: Amelia Ruffatti; Marta Tonello; L Punzi; A Banzato; A Calligaro; Teresa Del Ross; M Favaro; Vittorio Pengo
Risk-based secondary prevention of obstetric antiphospholipid syndrome.
Lupus 2012;21(7):741-3.
2012: Vittorio Pengo; A Banzato; E Bison; A Bracco; G Denas; M Facchinetti; A Hoxha; Amelia Ruffatti
Secondary prevention in thrombotic antiphospholipid syndrome.
Lupus 2012;21(7):734-5.
2012: Vittorio Pengo; M S Visentin; A Banzato; E Bison; A Bracco; G Denas; A Hoxha; Amelia Ruffatti
Interpretation of laboratory data and need for reference laboratories.
Lupus 2012;21(7):732-3.
2012: Paolo Prandoni; Martin H Prins; Maria Teresa Sartori; Maria C Ugolotti; Maria R Veropalumbo; Alessia Bracco; Angelo Ghirarduzzi; Franco Noventa; Vittorio Pengo; Anthonie W A Lensing
Family history of venous thrombosis or sudden death as a risk factor for venous thromboembolism.
Thrombosis and haemostasis 2012;107(6):1191-2.
2012: Vittorio Pengo; Alessandra Banzato; Elisa Bison; Alessia Bracco; Gentian Denas; Amelia Ruffatti
What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
Seminars in thrombosis and hemostasis 2012;38(4):322-7.
2012: Vittorio Pengo; Guillermo Ruiz-Irastorza; Laura Andreoli; Gentian Denas; Munther Khamashta; Angela Tincani
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'.
Autoimmunity reviews 2012;11(8):577-80.
2012: Gentian Denas; Vittorio Pengo
Current anticoagulant safety.
Expert opinion on drug safety 2012;11(3):401-13.
2012: Amelia Ruffatti; M T Gervasi; A Cerutti; Lino Chiandetti; G De Silvestro; O Milanesi; Vittorio Pengo; L Punzi
A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block?
Lupus 2012;21(6):666-71.
2012: Davide Ermacora; Seena Padayattil Jose; Gentian Denas; Beatrice Segafredo; Vittorio Pengo
An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation.
Internal and emergency medicine 2012;7 Suppl 1():S29-31.
2011: A Banzato; E Bison; Vincenzo De Filippis; G Denas; Roberta Frasson; S J Padayattil; N Pozzi; A Ruffatti; Vittorio Pengo
Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS).
Thrombosis research 2011;128(6):583-6.
2011: Armando Tripodi; Vittorio Pengo
More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required.
Journal of thrombosis and haemostasis : JTH 2011;9(10):2126-7.
2011: Amelia Ruffatti; Silvia Salvi; Marta Tonello; Maria S Visentin; Maria T Bertero; Marie C Boffa; Agnese Bontadi; Angela Botta; Valentina Canti; Sara De Carolis; Ariela Hoxha; Gorana Mitic; Marta Mosca; Monica Nuzzo; Vittorio Pengo; Patrizia Rovere-Querini; Angela Tincani
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.
Rheumatology (Oxford, England) 2011;50(9):1684-9.
2011: Francesca Maria Susin; Vincenzo Tarzia; Alessandro Bagno; Tomaso Bottio; Vittorio Pengo; Gino Gerosa
In-vitro detection of thrombotic formation on bileaflet mechanical heart valves.
The Journal of heart valve disease 2011;20(4):378-86.
2011: Armando Tripodi; M Moia; Vittorio Pengo
False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: a rebuttal.
Journal of thrombosis and haemostasis : JTH 2011;9(7):1435-6; author reply 1436-7.
2011: Clemens Romata; Francesca Maria Susin; Vincenzo Tarzia; Andrea Cambi; Gino Gerosa; Vittorio Pengo; Alessandro Bagno
Comparative classification of thrombotic formations on bileaflet mechanical heart valves by phonographic analysis.
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 2011;14(2):100-11.
2011: Armando Tripodi; Veena Chantarangkul; Marigrazia Clerici; Claudia Palmucci; Elisa Bison; Alessandra Banzato; Eugenia Biguzzi; Vittorio Pengo
Standardization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability.
Thrombosis research 2011;127(6):589-94.
2011: S Granziera; G Nante; E Manzato; Vittorio Pengo
Prescription of vitamin K inhibitors in low-risk patients with atrial fibrillation.
Journal of thrombosis and thrombolysis 2011;31(4):501-2.
2011: Giulia Angeloni; Silvia Alberti; Enrico Romagnoli; Alberto Banzato; Marco Formichi; Umberto Cucchini; Vittorio Pengo
Low molecular weight heparin (parnaparin) for cardioembolic events prevention in patients with atrial fibrillation undergoing elective electrical cardioversion: a prospective cohort study.
Internal and emergency medicine 2011;6(2):117-23.
2011: Gentian Denas; Vittorio Pengo
Emerging anticoagulants.
Expert opinion on emerging drugs 2011;16(1):31-44.
2011: Vittorio Pengo; Franco Noventa; Gentian Denas; Martino F Pengo; Umberto Gallo; Anna Maria Grion; Sabino Iliceto; Paolo Prandoni
Long-term use of vitamin K antagonists and incidence of cancer: a population-based study.
Blood 2011;117(5):1707-9.
2011: Vittorio Pengo
APS--controversies in diagnosis and management, critical overview of current guidelines.
Thrombosis research 2011;127 Suppl 3():S51-2.
2011: Vittorio Pengo
Antiphospholipid syndrome: interpretation of laboratory data.
Journal of thrombosis and haemostasis : JTH 2011;9(2):402-3.
2011: M Silvano; Carlo-Federico Zambon; G De Rosa; M Plebani; Vittorio Pengo; Massimo Napodano; R Padrini
A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty.
Journal of thrombosis and thrombolysis 2011;31(2):233-4.
2011: Carlo-Federico Zambon; Vittorio Pengo; Roberto Padrini; Daniela Basso; Stefania Schiavon; Paola Fogar; Alessandra Nisi; Anna Chiara Frigo; Stefania Moz; Michela Pelloso; Mario Plebani
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study.
Pharmacogenomics 2011;12(1):15-25.
2010: Roberto Padrini; Vittorio Pengo
Dosing of clopidogrel and aspirin in acute coronary syndromes.
The New England journal of medicine 2010;363(25):2465-6; author reply 2467-8.
2010: Alfonso Iorio; Clive Kearon; Esmeralda Filippucci; Maura Marcucci; Ana Macura; Vittorio Pengo; Sergio Siragusa; Gualtiero Palareti
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.
Archives of internal medicine 2010;170(19):1710-6.
2010: Martina Perazzolo Marra; Vittorio Pengo
Right ventricular dysfunction in patients diagnosed with pulmonary embolism.
Internal and emergency medicine 2010;5(5):451-2.
2010: Gian Paolo Fadini; Mattia Albiero; Lisa Menegazzo; Elisa Boscaro; Elisa Pagnin; Elisabetta Iori; Chiara Cosma; Annunziata Lapolla; Vittorio Pengo; Massimo Stendardo; Carlo Agostini; Pier Giuseppe Pelicci; Marco Giorgio; Angelo Avogaro
The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing.
Diabetes 2010;59(9):2306-14.
2010: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Sophie Testa; D Prisco; D Poli; Armando Tripodi; Gualtiero Palareti
Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension.
Journal of thrombosis and haemostasis : JTH 2010;8(9):1933-42.
2010: Vittorio Pengo; G Denas; E Bison; A Banzato; S Padayattil Jose; Paolo Gresele; Francesco Marongiu; Nicoletta Erba; F Veschi; Angelo Ghirarduzzi; E De Candia; B Montaruli; M Marietta; S Testa; Doris Barcellona; Armando Tripodi
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA).
Thrombosis research 2010;126(2):150-3.
2010: Marco Scarpa; Fabio Pilon; Vittorio Pengo; Giovanna Romanato; Cesare Ruffolo; Francesca Erroi; Bison Elisa; Mauro Frego; Elena Ossi; Enzo Manzato; Imerio Angriman
Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough?
World journal of surgery 2010;34(7):1629-36.
2010: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Sophie Testa; Domenico Prisco; Daniela Poli; Armando Tripodi; Gualtiero Palareti
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Thrombosis and haemostasis 2010;103(6):1152-60.
2010: Nicola Pozzi; Alessandra Banzato; Samuele Bettin; Elisa Bison; Vittorio Pengo; Vincenzo De Filippis
Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I.
Protein science : a publication of the Protein Society 2010;19(5):1065-78.
2010: Paolo Prandoni; E Casiglia; Andrea Piccioli; Angelo Ghirarduzzi; Vittorio Pengo; C Gu; J D Douketis
The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months.
Journal of thrombosis and haemostasis : JTH 2010;8(5):1126-7.
2010: Vittorio Pengo; Gentian Denas; Seena Padayattil Jose; Martino F Pengo
Cancer prevention and vitamin K antagonists: an overview.
Thrombosis research 2010;125 Suppl 2():S103-5.
2010: Vittorio Pengo; A Banzato; E Bison; G Denas; S Padayattil Jose; Amelia Ruffatti
Antiphospholipid syndrome: critical analysis of the diagnostic path.
Lupus 2010;19(4):428-31.
2010: Amelia Ruffatti; A Calligaro; A Hoxha; Daniele Trevisanuto; A T Ruffatti; M T Gervasi; S Cuffaro; Vittorio Pengo; Leonardo Punzi
Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome.
Arthritis care & research 2010;62(3):302-7.
2010: Vittorio Pengo; Umberto Cucchini; G Denas; B L Davidson; F Marzot; S P Jose; Sabino Iliceto
Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
Thrombosis and haemostasis 2010;103(2):442-9.
2010: Vittorio Pengo; A Ruffatti; Cristina Legnani; Paolo Gresele; Doris Barcellona; Nicoletta Erba; S Testa; Francesco Marongiu; E Bison; G Denas; A Banzato; S Padayattil Jose; Sabino Iliceto
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
Journal of thrombosis and haemostasis : JTH 2010;8(2):237-42.
2010: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Sophie Testa; Domenico Prisco; Daniela Poli; Armando Tripodi; Francesco Marongiu; Gualtiero Palareti
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study.
Blood 2010;115(3):481-8.
2010: Luciano Babuin; Vittorio Pengo
Argatroban in the management of heparin-induced thrombocytopenia.
Vascular health and risk management 2010;6():813-9.
2009: Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Adriano Alatri; Domenico Prisco; Daniela Poli; Armando Tripodi; Gualtiero Palareti
Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.
Journal of thrombosis and thrombolysis 2009;28(4):381-8.
2009: Vittorio Pengo; A Tripodi; G Reber; Jacob H Rand; T L Ortel; M Galli; P G De Groot
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
Journal of thrombosis and haemostasis : JTH 2009;7(10):1737-40.
2009: Vittorio Pengo; Gentian Denas; Seena Padayattil Jose
Vitamin K to correct overanticoagulation.
Annals of internal medicine 2009;151(6):433; author reply 435.
2009: Paolo Prandoni; Raffaele Pesavento; Henrik T Sørensen; Nicola Gennaro; Fabio Dalla Valle; Isabella Minotto; Fabio Perina; Vittorio Pengo; Antonio Pagnan
Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey.
European journal of internal medicine 2009;20(5):470-3.
2009: David Garcia; Walter Ageno; Henry Bussey; John Eikelboom; Maurizio Margaglione; Francesco Marongiu; Marco Moia; Gualtiero Palareti; Vittorio Pengo; Daniela Poli; Sam Schulman; Dan Witt; Ann Wittkowksy; Mark Crowther
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.
American journal of hematology 2009;84(9):579-83.
2009: Filippo Marzot; Vittorio Pengo
Mild inflammation may switch on again atrial fibrillation after successful electrical cardioversion.
Internal and emergency medicine 2009;4(4):277-8.
2009: Vittorio Pengo; Umberto Cucchini; G Denas; N Erba; Giuliana Guazzaloca; L La Rosa; V De Micheli; S Testa; R Frontoni; D Prisco; G Nante; Sabino Iliceto
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Circulation 2009;119(22):2920-7.
2009: Anna Cavazzana; Vittorio Pengo; Marta Tonello; Franco Noventa; Claudia Grossi; Maria Orietta Borghi; Philippe de Moerloose; Guido Reber; Amelia Ruffatti
Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations.
Thrombosis and haemostasis 2009;101(4):789-91.
2009: James D Douketis; C Gu; A Piccioli; Angelo Ghirarduzzi; Vittorio Pengo; Paolo Prandoni
The long-term risk of cancer in patients with a first episode of venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2009;7(4):546-51.
2009: G Denas; F Marzot; P Offelli; A Stendardo; Umberto Cucchini; R Russo; G Nante; Sabino Iliceto; Vittorio Pengo
Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
Journal of thrombosis and thrombolysis 2009;27(3):340-7.
2009: Andrea Bagno; Federico Anzil; Vincenzo Tarzia; Vittorio Pengo; Alfredo Ruggeri; Gino Gerosa
Application of wavelet analysis to the phonocardiographic signal of mechanical heart valve closing sounds.
The International journal of artificial organs 2009;32(3):166-72.
2009: Andrea Bagno; Federico Anzil; Roberto Buselli; Vincenzo Tarzia; Tomaso Bottio; Gino Gerosa; Vittorio Pengo
Is the analysis over the time domain or over the frequency domain significant for the detection of bileaflet mechanical heart valve dysfunction?
The Annals of thoracic surgery 2009;87(3):986-7; author reply 987-8.
2009: Gentian Denas; Umberto Cucchini; Sabino Iliceto; Vittorio Pengo
An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
Thrombosis and haemostasis 2009;101(2):410-1.
2009: Maria Bortolati; Piero Marson; Fabrizio Fabris; Vittorio Pengo; Myriam Facchinetti; Giustina De Silvestro; Amelia Ruffatti
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature.
Autoimmunity reviews 2009;8(4):297-301.
2009: Andrea Bagno; Federico Anzil; Roberto Buselli; Elena Pesavento; Vincenzo Tarzia; Vittorio Pengo; Tomaso Bottio; Gino Gerosa
Bileaflet mechanical heart valve closing sounds: in vitro classification by phonocardiographic analysis.
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 2009;12(3):172-81.
2009: Filippo Marzot; Vittorio Pengo
Prasugrel for the treatment of patients with acute coronary syndrome.
Vascular health and risk management 2009;5(1):321-4.
2009: Amelia Ruffatti; Marta Tonello; Anna Cavazzana; Paola Bagatella; Vittorio Pengo
Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
Thrombosis research 2009;123(3):482-7.
2008: Vittorio Pengo; Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Adriano Alatri; Filippo Marzot; Cinzia Pegoraro; Umberto Cucchini; Sabino Iliceto
D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study.
Thrombosis and haemostasis 2008;100(4):718-21.
2008: Amelia Ruffatti; S Olivieri; Marta Tonello; Maria Bortolati; E Bison; E Salvan; M Facchinetti; Vittorio Pengo
Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1693-6.
2007: James D Douketis; Chu Shu Gu; Sam Schulman; Angelo Ghirarduzzi; Vittorio Pengo; Paolo Prandoni
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
Annals of internal medicine 2007;147(11):766-74.
2007: Francesco Baudo; Francesco de Cataldo; G Mostarda; Angelo Ghirarduzzi; M Molinatti; Vittorio Pengo; D Poli; Alberto Tosetto; E Tiraferri; E Morra
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics.
Internal and emergency medicine 2007;2(4):280-4.
2007: Vittorio Pengo; Alessandra Biasiolo; Paolo Gresele; Francesco Marongiu; Nicoletta Erba; Fabio Veschi; Angelo Ghirarduzzi; Doris Barcellona; Armando Tripodi
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(12):e309-10.
2007: Pietro Offelli; Mario Zanchetta; Luigi Pedon; Filippo Marzot; Umberto Cucchini; Cinzia Pegoraro; Sabino Iliceto; Vittorio Pengo
Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO).
Thrombosis and haemostasis 2007;98(4):906-7.
2007: Vittorio Pengo; Amelia Ruffatti
Laboratory diagnosis of antiphospholipid syndrome.
Reumatismo 2007;59(3):187-91.
2007: Vittorio Pengo; Gualtiero Palareti; Umberto Cucchini; Maurizio Molinatti; Roberto Del Bono; Francesco Baudo; Angelo Ghirarduzzi; Cinzia Pegoraro; Sabino Iliceto
Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(3):241-8.
2007: Vittorio Pengo; Alessandra Biasiolo; Paolo Gresele; Francesco Marongiu; Nicoletta Erba; F Veschi; Angelo Ghirarduzzi; E de Candia; B Montaruli; S Testa; Doris Barcellona; Armando Tripodi
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples.
Journal of thrombosis and haemostasis : JTH 2007;5(5):925-30.
2007: Paolo Prandoni; Franco Noventa; Angelo Ghirarduzzi; Vittorio Pengo; Enrico Bernardi; Raffaele Pesavento; Matteo Iotti; Daniela Tormene; Paolo Simioni; Antonio Pagnan
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
Haematologica 2007;92(2):199-205.
2007: Amelia Ruffatti; Piero Marson; Vittorio Pengo; Maria Favaro; Marta Tonello; Maria Bortolati; Daria Minucci; Giustina De Silvestro
Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature.
Autoimmunity reviews 2007;6(3):196-202.
2007: Vittorio Pengo; Alessandra Biasiolo; Elisa Bison; Veena Chantarangkul; Armando Tripodi
Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
Thrombosis research 2007;120(1):127-33.
2006: Vittorio Pengo
Management of oral anticoagulant treatment in patients with venous thromboembolism.
Seminars in thrombosis and hemostasis 2006;32(8):781-6.
2006: Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Carlotta Brusi; Alfonso Iorio; Vittorio Pengo; Angelo Ghirarduzzi; Corrado Pattacini; Sophie Testa; Anthonie W A Lensing; Armando Tripodi
D-dimer testing to determine the duration of anticoagulation therapy.
The New England journal of medicine 2006;355(17):1780-9.
2006: Paolo Prandoni; Angelo Ghirarduzzi; Martin H Prins; Vittorio Pengo; B L Davidson; H Sørensen; Raffaele Pesavento; M Iotti; E Casiglia; Sabino Iliceto; Antonio Pagnan; Anthonie W A Lensing
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis.
Journal of thrombosis and haemostasis : JTH 2006;4(9):1891-6.
2006: Amelia Ruffatti; Marta Tonello; Teresa Del Ross; Anna Cavazzana; Chiara Grava; Franco Noventa; Francesco Tona; Sabino Iliceto; Vittorio Pengo
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.
Thrombosis and haemostasis 2006;96(3):337-41.
2006: Vittorio Pengo
Should patients with mitral stenosis and atrial fibrillation receive combined antithrombotic therapy?
Nature clinical practice. Cardiovascular medicine 2006;3(8):412-3.
2006: Vittorio Pengo; Paolo Prandoni
Sex and anticoagulation in patients with idiopathic venous thromboembolism.
Lancet 2006;368(9533):342-3.
2006: Vittorio Pengo; Cinzia Pegoraro; Umberto Cucchini; Sabino Iliceto
Worldwide management of oral anticoagulant therapy: the ISAM study.
Journal of thrombosis and thrombolysis 2006;21(1):73-7.
2006: Francesca Elisa Bovolato; Umberto Cucchini; Angelo Ramondo; Massimo Napodano; Maria Luisa Schiavinato; Claudio Bilato; Cristiano Sarais; Sabino Iliceto; Vittorio Pengo
Positive stress test in a patient with patent coronary artery grafts.
Internal and emergency medicine 2006;1(4):296-9.
2006: Vittorio Pengo
Monitoring oral anticoagulants: new strategies for an emerging problem.
Internal and emergency medicine 2006;1(1):3-4.
2006: Vittorio Pengo; Amelia Ruffatti; Sabino Iliceto
The diagnosis of the antiphospholipid syndrome.
Pathophysiology of haemostasis and thrombosis 2006;35(1-2):175-80.
2006: Panagiotis Grypiotis; Amelia Ruffatti; Vittorio Pengo; Marta Tonello; Alessandra Biasiolo; Daniela Zamboni; Anna Cavazzana; Silvano Todesco
Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome.
Journal of clinical laboratory analysis 2006;20(1):15-8.
2005: Vittorio Pengo; Paolo Prandoni
From acute pulmonary embolism to chronic thromboembolic pulmonary hypertension.
Italian heart journal : official journal of the Italian Federation of Cardiology 2005;6(10):830-3.
2005: Vittorio Pengo; Alessandra Biasiolo; Cinzia Pegoraro; Umberto Cucchini; Franco Noventa; Sabino Iliceto
Antibody profiles for the diagnosis of antiphospholipid syndrome.
Thrombosis and haemostasis 2005;93(6):1147-52.
2005: Vittorio Pengo
Anti-beta2-glycoprotein I antibody testing in the laboratory diagnosis of antiphospholipid syndrome.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1158-9.
2005: Angelo Ramondo; Giuseppe Maiolino; Massimo Napodano; Gianbattista Isabella; Giuseppe Tarantini; Raffaele Bonato; Vittorio Pengo; Andrea Ponchia; Sabino Iliceto
Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation.
Italian heart journal : official journal of the Italian Federation of Cardiology 2005;6(5):414-7.
2005: Gualtiero Palareti; Cristina Legnani; Giuliana Guazzaloca; Valdré Lelia; Benilde Cosmi; Barbara Lunghi; Giovanna Marchetti; Daniela Poli; Vittorio Pengo
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
British journal of haematology 2005;129(1):72-8.
2005: Vittorio Pengo
Antithrombotic strategies for atrial fibrillation: on the threshold of changes? No.
Journal of thrombosis and haemostasis : JTH 2005;3(3):433-5.
2005: Vittorio Pengo
New trends in anticoagulant treatments.
Lupus 2005;14(9):789-93.
2005: Amelia Ruffatti; Maria Favaro; Marta Tonello; Giustina De Silvestro; Vittorio Pengo; G Fais; Vincenzo Suma; Silvia Chiarelli; Silvano Todesco
Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study.
Lupus 2005;14(2):120-8.
2004: Vittorio Pengo
Long-term warfarin use to prevent both stroke and dementia in subjects with atrial fibrillation?
Journal of thrombosis and haemostasis : JTH 2004;2(11):1871-2.
2004: Vittorio Pengo; Cinzia Pegoraro; Sabino Iliceto
New trends in anticoagulant therapy.
The Israel Medical Association journal : IMAJ 2004;6(8):479-81.
2004: Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.
The New England journal of medicine 2004;350(22):2257-64.
2004: Vittorio Pengo; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto
A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants.
Journal of thrombosis and haemostasis : JTH 2004;2(5):702-7.
2003: Vittorio Pengo; Fabio Barbero; Alessandra Biasiolo; Cinzia Pegoraro; Umberto Cucchini; Sabino Iliceto
A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment.
American journal of clinical pathology 2003;120(6):944-7.
2003: Armando Tripodi; Alessandra Biasiolo; Veena Chantarangkul; Vittorio Pengo
Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity.
Clinical chemistry 2003;49(10):1608-14.
2003: Vittorio Pengo
Oral anticoagulant therapy in patients with atrial fibrillation.
Seminars in vascular medicine 2003;3(3):333-8.
2003: Vittorio Pengo; Fabio Barbero; Alessandra Biasiolo; Cinzia Pegoraro; Franco Noventa; Sabino Iliceto
Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment.
Thrombosis and haemostasis 2003;89(4):760-4.
2003: Cinzia Pegoraro; Alessandra Biasiolo; Sabino Iliceto; Vittorio Pengo
Mechanical prosthetic heart valve thrombosis despite optimal anticoagulation in a patient with congenital thrombophilia (factor V Leiden).
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2003;9(1):89-90.
2002: Vittorio Pengo; Barbara Filippi; Alessandra Biasiolo; Cinzia Pegoraro; Franco Noventa; Sabino Iliceto
Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation.
The American journal of cardiology 2002;90(5):545-7.
2002: Vittorio Pengo; Domenico Prisco; Sabino Iliceto
[Current management of oral anticoagulant treatment].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 2002;3(5):502-17.
2002: Anna Maria Grion; Umberto Gallo; Francesca Bano; Michele Ragazzi; Adriano Cestrone; Arturo Orsini; Marina Salomoni; Rosa Maria Gaion; Vittorio Pengo
Difference in mortality after hip fracture is associated with postdischarge prescription of antithrombotic prophylaxis: a case-control study.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(2):143-6.
2001: Vittorio Pengo; Alessandra Biasiolo; Cinzia Pegoraro
A simple scheme to initiate oral anticoagulant treatment in outpatients with nonrheumatic atrial fibrillation.
The American journal of cardiology 2001;88(10):1214-6.
2001: C Manotti; Marco Moia; Gualtiero Palareti; Vittorio Pengo; L Ria; A G Dettori
Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment).
Haematologica 2001;86(10):1060-70.
2001: Vittorio Pengo
[Thromboembolism in non-rheumatic atrial fibrillation].
Haematologica 2001;86(9 Suppl):5-11.
2001: Vittorio Pengo; R De Caterina
[Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 2001;2(9):972-9.
2001: Vittorio Pengo; Alessandra Biasiolo
The risk of overdiagnosis of antiphospholipid antibody syndrome.
Thrombosis and haemostasis 2001;86(3):933.
2001: Vittorio Pengo; C Legnani; Franco Noventa; Gualtiero Palareti
Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
Thrombosis and haemostasis 2001;85(3):418-22.
2001: P Rampazzo; Alessandra Biasiolo; J Garin; A Rosato; C Betterle; Amelia Ruffatti; Vittorio Pengo
Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins.
Thrombosis and haemostasis 2001;85(1):57-62.
2000: Benilde Cosmi; Gualtiero Palareti; M Moia; M Carpenedo; Vittorio Pengo; Alessandra Biasiolo; P Rampazzo; Giampietro Morstabilini; Sophie Testa
Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic oral anticoagulant therapy: a prospective multicenter study.
Thrombosis research 2000;100(4):279-86.
2000: Gualtiero Palareti; Cristina Legnani; A Lee; C Manotti; J Hirsh; A D'Angelo; Vittorio Pengo; Marco Moia; Sergio Coccheri
A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.
Thrombosis and haemostasis 2000;84(5):805-10.
2000: Benilde Cosmi; Gualtiero Palareti; M Carpanedo; Vittorio Pengo; Alessandra Biasiolo; P Rampazzo; Giampietro Morstabilini; Sophie Testa
Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
Haematologica 2000;85(8):826-31.
2000: G Russo; L D Corso; Alessandra Biasiolo; Mario Berengo; Vittorio Pengo
Simple and safe method to prepare patients with prosthetic heart valves for surgical dental procedures.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2000;6(2):90-3.
2000: Alessandra Biasiolo; P Rampazzo; O Furnari; Barbara Filippi; Vittorio Pengo
Comparison between routine laboratory prothrombin time measurements and fingerstick determinations using a near-patient testing device (Pro-Time).
Thrombosis research 2000;97(6):495-8.
2000: Gualtiero Palareti; J Hirsh; Cristina Legnani; C Manotti; A D'Angelo; Vittorio Pengo; Marco Moia; Giuliana Guazzaloca; Serena Musolesi; Sergio Coccheri
Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.
Archives of internal medicine 2000;160(4):470-8.
2000: Vittorio Pengo; Alessandra Biasiolo; T Brocco; P Rampazzo
Effect of anti-beta2glycoprotein I Lupus Anticoagulants on fibrin polymerization and fibrinolysis.
Autoimmunity 2000;32(1):39-44.
2000: Doris Barcellona; Paolo Contu; GG Sorano; Vittorio Pengo; Francesco Marongiu
The management of oral anticoagulant therapy: the patient's point of view.
Thrombosis and haemostasis 2000;83(1):49-53.
1999: Benilde Cosmi; Gualtiero Palareti; M Moia; Vittorio Pengo; Sophie Testa
[Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study].
Minerva cardioangiologica 1999;47(12):598-9.
1999: Vittorio Pengo; T Brocco; Alessandra Biasiolo; P Rampazzo; Paolo Carraro; Rita Zamarchi
Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity.
Blood 1999;94(11):3814-9.
1999: Vittorio Pengo; Alessandra Biasiolo; P Rampazzo; T Brocco
dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
Thrombosis and haemostasis 1999;81(2):256-8.
1999: Alessandra Biasiolo; P Rampazzo; T Brocco; Fabio Barbero; A Rosato; Vittorio Pengo
[Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
Lupus 1999;8(2):121-6.
1998: Vittorio Pengo; A Zasso; Fabio Barbero; A Banzato; G Nante; L Parissenti; N John; Franco Noventa; Sergio Dalla Volta
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.
The American journal of cardiology 1998;82(4):433-7.
1997: Gualtiero Palareti; C Manotti; A DAngelo; Vittorio Pengo; Nicoletta Erba; Marco Moia; N Ciavarella; G Devoto; M Berrettini; N Leali; M Poggi; Cristina Legnani; Serena Musolesi; Sergio Coccheri
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy).
Thrombosis and haemostasis 1997;78(6):1438-43.
1997: Vittorio Pengo; A Zasso; Fabio Barbero; E Garelli; Alessandra Biasiolo
Low intensity warfarin therapy.
Haematologica 1997;82(6):710-2.
1997: Vittorio Pengo; Fabio Barbero; A Banzato; E Garelli; Franco Noventa; Alessandra Biasiolo; A Zasso; Sergio Dalla Volta
A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
Thrombosis and haemostasis 1997;77(5):839-44.
1997: Gualtiero Palareti; N Leali; Sergio Coccheri; M Poggi; C Manotti; A D'Angelo; Vittorio Pengo; Nicoletta Erba; Marco Moia; N Ciavarella; G Devoto; M Berretini; Serena Musolesi
[Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
Giornale italiano di cardiologia 1997;27(3):231-43.
1997: Vittorio Pengo; Genesio Balestrieri; Angela Tincani; L Spatola; Alessandra Biasiolo; T Brocco
Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
Thrombosis and haemostasis 1997;77(1):123-6.
1996: Vittorio Pengo; Alessandra Biasiolo; Piero Marson; Giustina De Silvestro; C Agostini; U Livi
Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome.
Clinical rheumatology 1996;15(5):504-7.
1996: Gualtiero Palareti; N Leali; Sergio Coccheri; M Poggi; C Manotti; A D'Angelo; Vittorio Pengo; Nicoletta Erba; Marco Moia; N Ciavarella; G Devoto; M Berrettini; Serena Musolesi
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
Lancet 1996;348(9025):423-8.
1996: F Bellotto; G De Simone; J Assatourian; Vittorio Pengo
[Primary pulmonary hypertension and anticoagulant therapy].
Cardiologia (Rome, Italy) 1996;41(8):699-706.
1996: Vittorio Pengo; Alessandra Biasiolo; T Brocco; S Tonetto; Amelia Ruffatti
Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
Thrombosis and haemostasis 1996;75(5):721-4.
1995: Vittorio Pengo; Alessandra Biasiolo; M Grazia Fior; Amelia Ruffatti
Anti beta 2-glycoprotein I antibodies in a patient with catastrophic antiphospholipid syndrome.
Clinical rheumatology 1995;14(6):646-9.
1995: Vittorio Pengo; Alessandra Biasiolo; M G Fior
Binding of autoimmune cardiolipin-reactive antibodies to heparin: a mechanism of thrombosis?
Thrombosis research 1995;78(5):371-8.
1995: Vittorio Pengo; Alessandra Biasiolo; M G Fior
Autoimmune antiphospholipid antibodies: what is their true target?
Haematologica 1995;80(2 Suppl):127-30.
1995: Vittorio Pengo; Alessandra Biasiolo; M G Fior
Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Thrombosis and haemostasis 1995;73(1):29-34.
1993: Vittorio Pengo; Alessandra Biasiolo
Purification of anticardiolipin and lupus anticoagulant activities by using cardiolipin immobilized on agarose beads.
Thrombosis research 1993;72(5):423-30.
1993: Vittorio Pengo; A Banzato; E Garelli; A Zasso; Alessandra Biasiolo
Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1993;4(5):739-41.
1993: Alessandra Biasiolo; Vittorio Pengo
Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1993;4(3):425-8.
1990: P A Ostuni; P Lazzarin; Vittorio Pengo; Amelia Ruffatti; Franco Schiavon; Pier Franca Gambari
Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome.
Annals of the rheumatic diseases 1990;49(3):184-7.
1990: Vittorio Pengo; M Boschello; M Baca; A Marzari; A Banzato; G Ferrari; L Shivazappa; Sergio Dalla Volta
A brief contact of native whole blood with adenosine diphosphate (ADP) promotes the release of the contents of platelet alpha granules but not dense bodies and increases platelet retention to glass bead columns.
Folia haematologica (Leipzig, Germany : 1928) 1990;117(3):359-64.
1989: Vittorio Pengo; P Peruzzi; A Marzari; F Zanon; A Banzato; L Schivazappa
[Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs].
Giornale italiano di cardiologia 1989;19(12):1125-8.
1989: Vittorio Pengo; P Peruzzi; M Baca; A Marzari; F Zanon; L Schivapappa; Sergio Dalla Volta
The optimal therapeutic range for oral anticoagulant treatment as suggested by fibrinopeptide A (FpA) levels in patients with heart valve prostheses.
European journal of clinical investigation 1989;19(2):181-4.
1987: P A Battistella; M Cavinato; P Cogo; P Facchin; L Lovison; Vittorio Pengo; L Schivazappa
[Study of blood platelet activation in migraine in childhood].
Minerva medica 1987;78(14):1051-2.
1986: Vittorio Pengo; M Boschello; A Marzari; M Baca; L Schivazappa; Sergio Dalla Volta
Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
Thrombosis and haemostasis 1986;56(2):147-50.
1986: P Prandoni; R Russo; Vittorio Pengo; M Boschello; Dario Casara; Francesco Maddalena; L Schivazappa
[Prevention of deep venous thrombosis with low-dose heparin in patients with acute uncomplicated myocardial infarct: double-blind controlled study].
Minerva cardioangiologica 1986;34(10):653-7.
1985: R Russo; P Prandoni; Vittorio Pengo; M Boschello; L Schivazappa
[Thrombolytic therapy with urokinase in 8 patients with massive pulmonary thromboembolism].
Giornale italiano di cardiologia 1985;15(10):957-9.
1985: Vittorio Pengo; M Boschello; P Prandoni; L Schivazappa; A Girolami
Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
Thrombosis research 1985;39(5):645-50.
1985: Vittorio Pengo; M Boschello; P Prandoni; R Schiavon; F Bellotto; L Schivazappa; Sergio Dalla Volta
Enhanced "in vitro" release of platelet alpha-granules after acute myocardial infarction (AMI).
Thrombosis and haemostasis 1985;54(2):544-6.
1984: R Russo; P Prandoni; Vittorio Pengo; M Boschello; L Compostella; L Schivazappa
[Effect of the degree of anticoagulation on the plasma levels of beta-thromboglobulin in patients with heart valve prostheses treated with warfarin].
Minerva cardioangiologica 1984;32(6):387-91.
1983: Vittorio Pengo; G Cartei; Dario Casara; O Daniele; MV Fiorentino
The evaluation of fibrinogen behavior in Hodgkin's disease: correlation with clinical stage.
Tumori 1983;69(2):123-7.
1982: Vittorio Pengo; C Guerra; G Cartei; M Fiorentino
Behavior of antithrombin III, determined as protein concentration and biologic activity, in subjects with neoplastic disease.
Tumori 1982;68(3):205-9.
1982: P A Battistella; Vittorio Pengo; G Meneghetti; D Martines; P Cadrobbi
[Neurologic complications of acute viral hepatitis. Electroencephalographic and biohumoral aspects].
Rivista di neurologia 1982;52(2):83-96.
1981: F Carmignoto; P Schivo; M Plebani; Vittorio Pengo; P Piccini; G Ceriotti
[Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
Quaderni Sclavo di diagnostica clinica e di laboratorio 1981;17(2):172-81.
1981: Vittorio Pengo; E Bertaglia; F Carmignoto; P Schivo; C Guerra
[Abnormal fibrin polymerization and its clinical usefulness in patients with chronic liver disease (author's transl)].
Haematologica 1981;66(2):171-80.
1980: E Bertaglia; Vittorio Pengo; C Guerra; U Vertolli
[Coagulation disorders after placement of a peritoneojugular valve].
Gastroentérologie clinique et biologique 1980;4(5):388.